Opinion | I Led A.I. Diplomacy for the U.S. The Coming Safety Talks Will Not Save Us.
By Gammatek ISPL, Industrial Systems & Compliance Analyst at Gammatek ISPL
Last updated: September 2026 | 14 min read
Author block: Gammatek ISPL advises manufacturing, chemical, and pharmaceutical organizations on compliance and risk management systems at Gammatek ISPL. This analysis draws on public reporting of the U.S.-China AI safety dialogue and Gammatek's direct experience helping industrial clients build AI-era risk management processes.
Why This Matters to You Right Now
Formal AI safety talks between the United States and China are moving forward, tied to the broader Trump-Xi summit track, with U.S. Treasury Secretary Scott Bessent publicly framing the American position as one of negotiating from strength — "we are in the lead," as he put it — rather than parity. If you run or manage a business that touches AI in any way — and by 2026, that's most manufacturing, chemical, and pharma operations — it's tempting to assume these high-level talks are where AI safety gets handled, and that your own risk exposure will be covered by whatever comes out of Geneva, Washington, or Beijing. It won't be. These talks, even in the best case, are aimed at a narrow slice of the problem: state-level competition, non-state actor access to frontier models, and broad geopolitical framing. The actual risk your organization carries — a vendor's AI system making a bad call in your supply chain, an automated compliance tool missing an audit flag, an AI-assisted process failing in a way no regulator has yet defined — sits entirely outside the scope of any diplomatic protocol. That gap is what this piece is actually about.
What the Talks Are Actually About
It's worth being precise about what's on the table, because vague "AI safety talks" framing invites people to assume more is being solved than actually is. Based on public reporting, the substantive hook for the September round of U.S.-China discussions is narrow: a protocol focused on best practices to prevent non-state actors from gaining access to powerful AI models, positioned by the U.S. Treasury Secretary as something Washington can afford to discuss "because we are in the lead" technologically. That framing — leading from strength rather than approaching the talks as an equal negotiation over shared risk — tends to produce narrower, more defensive agreements than expansive safety frameworks.
Independent observers, including a former U.S. diplomat now working on AI safety policy, have been candid that trust between the two sides remains low, past efforts have devolved into airing grievances or been derailed by unrelated disputes, and there's no guarantee the September talks will even reach the technical substance rather than stalling on political framing. Meanwhile, Chinese state media has already criticized U.S. AI governance and specific American AI companies' lobbying posture ahead of the talks — not exactly the tone of a negotiation heading toward comprehensive agreement.
Everything inside the outer ring is left for individual organizations to manage themselves."
Put simply: even a fully successful outcome from these talks would produce a government-to-government framework aimed at state-level and non-state-actor risks. It would not produce a standard for how a mid-size manufacturer validates an AI-powered quality control system, how a pharma plant documents an AI-assisted compliance decision for an FDA audit, or how a chemical plant assesses whether a vendor's "AI-enhanced" monitoring tool meets its actual safety requirements.
A Pattern Worth Recognizing: Diplomacy Solves State Problems, Not Operational Ones
This isn't a new pattern, and recognizing it helps calibrate expectations correctly. International agreements on nuclear safety didn't eliminate the need for individual power plants to run their own safety management systems — they set a baseline state-level framework, and operational risk management still had to be built plant by plant. Financial regulation coordinated internationally through bodies like the Basel Committee didn't eliminate the need for individual banks to run their own enterprise risk management software and internal compliance functions — it set minimum standards that individual institutions still had to operationalize, often well beyond the regulatory floor.
AI safety is following the same shape. Whatever protocol emerges from U.S.-China talks will set expectations at the level of nation-states and frontier AI developers — not at the level of the thousands of companies deploying AI tools inside their own operations, supply chains, and compliance processes. That operational layer has always been, and will remain, the responsibility of individual organizations.
The Real Risk Surface Companies Are Actually Facing
Here's what's actually landing on risk and compliance teams right now, based on the patterns we see across manufacturing and industrial clients:
Vendor AI risk. Plants increasingly rely on third-party software with embedded AI features — predictive maintenance tools, quality control vision systems, automated compliance monitoring — without a clear internal process for validating what those AI components actually do, how they fail, or what happens when they're wrong. No diplomatic talk addresses this; it's a vendor management and enterprise risk management software problem specific to your organization.
Documentation gaps for regulators. When an AI-assisted process contributes to a decision — a quality control flag, a maintenance prioritization, a compliance determination — auditors and regulators increasingly want to see how that decision was made and reviewed. Enterprise compliance software built for this purpose creates that documentation trail; hoping a future international standard will define it for you is not a plan.
Governance ambiguity. Most mid-size industrial organizations don't yet have a clear internal policy for what AI tools are approved for what purposes, who signs off on new deployments, or how exceptions get escalated. This is precisely what enterprise policy management software and enterprise governance software are built to formalize — and it's an internal governance question no international treaty will resolve for you.
Supply chain exposure. If a supplier's AI-driven forecasting or automated ordering system fails or behaves unpredictably, that risk flows directly into your operations regardless of what any government agreement says about frontier model safety. Corporate risk management software that models supply-chain dependencies, including AI-driven vendor systems, is the actual tool for this — not diplomacy.
Risk Category | Covered by U.S.-China Talks? | Who Actually Owns It |
Non-state actor access to frontier models | Yes (stated focus) | National governments, frontier AI labs |
State-level AI arms race dynamics | Partially | National governments |
Vendor AI tool validation | No | Your organization's procurement/risk team |
Audit documentation for AI-assisted decisions | No | Your compliance function |
Internal AI use policy and governance | No | Your organization's leadership/governance function |
Supply chain AI dependency risk | No | Your risk management function |
An Implementation Consideration: What This Actually Looks Like Day to Day
For a plant or manufacturing operation, closing this gap in practice usually looks like three concrete steps rather than waiting for external clarity:
Inventory where AI already touches your operations — including AI features embedded in software you didn't originally select for AI capability (many monitoring, ERP, and quality tools have quietly added AI features via updates). Most organizations underestimate this number significantly on first review.
Assign clear ownership for AI-related risk decisions through your existing enterprise risk management software or governance structure, rather than treating it as a new, undefined category that falls between IT, compliance, and operations.
Build the audit trail before a regulator asks for it. Waiting until an inspection or incident to document how an AI-assisted process was validated is a materially weaker position than having enterprise compliance software already generating that record as a normal part of operations.
None of this requires waiting for Washington and Beijing to finish talking. It's work that's fully within an organization's control today, using the same risk management discipline already applied to safety, quality, and financial controls.
What Happens If the Talks Fail, Stall, or Only Partially Succeed
It's worth planning for the realistic range of outcomes rather than assuming success. Given the low trust described by observers on both sides, and the narrow substantive scope already signaled publicly, a plausible range of outcomes includes: a limited, symbolic first framework that mostly formalizes an ongoing dialogue channel; a stalled process that produces no binding commitments before geopolitical tensions (Taiwan among them) reassert themselves; or, in the better case, a narrow but real agreement specifically on non-state actor access, without touching broader AI safety practices.
In every one of these scenarios, the operational risk management gap described above remains exactly the same size. Organizations that built their own AI governance and enterprise risk management processes regardless of the diplomatic outcome will be in the same position either way — prepared. Organizations that were implicitly waiting for the talks to define acceptable AI risk practices will find themselves exactly where they started, regardless of what headline comes out of the summit.
The Honest Takeaway
The coming AI safety talks are a real, meaningful diplomatic development — worth watching, and potentially an important step in managing state-level AI competition. But treating them as a substitute for your own organization's AI risk management is a category error. Diplomacy operates at the level of nations and frontier labs; your actual exposure operates at the level of the specific vendors, systems, and processes running inside your plant today. Closing that gap has always been, and remains, an internal responsibility — one that a solid enterprise risk management and compliance foundation handles regardless of how any international summit turns out.
Where Gammatek Fits
If your organization is still treating AI risk as an open question waiting on external clarity, that's the gap Gammatek's compliance and risk management platform is built to close — giving manufacturing, chemical, and pharma operations a clear system for governing AI-touched processes, documenting decisions for auditors, and managing vendor risk without waiting for a diplomatic framework that was never going to cover your operations in the first place.
See how Gammatek's compliance platform handles AI-era risk documentation → https://www.gammateksolutions.com/post/the-best-worst-and-strangest-ways-ai-is-really-being-used-at-work https://www.gammateksolutions.com/post/ai-hasn-t-gone-rough-its-worst-than-that
Comments